Baker's yeast (Saccharomyces cerevisiae) antigen in obese and normal weight subjects

Summary Baker's yeast (Saccharomyces cerevisiae) and its cell wall components have been used as one of the alternatives to antibiotic growth promoters in the feed industry. Antibodies to cell wall mannan of this yeast (ASCA) have been traditionally used in the study of Crohn's disease (CD)...

Full description

Saved in:
Bibliographic Details
Published inClinical obesity Vol. 5; no. 1; pp. 42 - 47
Main Authors Salamati, S., Martins, C., Kulseng, B.
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.02.2015
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text
ISSN1758-8103
1758-8111
DOI10.1111/cob.12079

Cover

Abstract Summary Baker's yeast (Saccharomyces cerevisiae) and its cell wall components have been used as one of the alternatives to antibiotic growth promoters in the feed industry. Antibodies to cell wall mannan of this yeast (ASCA) have been traditionally used in the study of Crohn's disease (CD). We applied ASCA in relation to obesity. This study aims (i) to determine the concentration of ASCA (immunoglobulin A [IgA] and immunoglobulin G [IgG]) in obese compared with normal weight individuals and (ii) to determine if there is a correlation between ASCA concentrations, obesity indices and C‐reactive protein. Forty obese individuals (body mass index [BMI] > 35 kg m−2) and 18 healthy (BMI < 25 kg m−2) volunteers participated in this case–control study. Binding activity of serum IgA and IgG to the cell wall mannan of S. cerevisiae was measured by enzyme‐linked immunosorbent assay. More than one‐third of the obese individual (35%) showed elevated titres of ASCA compared with the control group (5%). This antibody was positively associated with weight (P = 0.01), BMI (P = 0.02) and waist circumference (P = 0.02), but not with C‐reactive protein. It seems that ASCA are not only specific for CD but are also associated with obesity. S. cerevisiae or a related antigen may play a role in the matrix of this complex condition.
AbstractList Baker's yeast (Saccharomyces cerevisiae) and its cell wall components have been used as one of the alternatives to antibiotic growth promoters in the feed industry. Antibodies to cell wall mannan of this yeast (ASCA) have been traditionally used in the study of Crohn's disease (CD). We applied ASCA in relation to obesity. This study aims (i) to determine the concentration of ASCA (immunoglobulin A [IgA] and immunoglobulin G [IgG]) in obese compared with normal weight individuals and (ii) to determine if there is a correlation between ASCA concentrations, obesity indices and C-reactive protein. Forty obese individuals (body mass index [BMI]>35kgm super(-2)) and 18 healthy (BMI<25kgm super(-2)) volunteers participated in this case-control study. Binding activity of serum IgA and IgG to the cell wall mannan of S.cerevisiae was measured by enzyme-linked immunosorbent assay. More than one-third of the obese individual (35%) showed elevated titres of ASCA compared with the control group (5%). This antibody was positively associated with weight (P=0.01), BMI (P=0.02) and waist circumference (P=0.02), but not with C-reactive protein. It seems that ASCA are not only specific for CD but are also associated with obesity. S.cerevisiae or a related antigen may play a role in the matrix of this complex condition.
Summary Baker's yeast (Saccharomyces cerevisiae) and its cell wall components have been used as one of the alternatives to antibiotic growth promoters in the feed industry. Antibodies to cell wall mannan of this yeast (ASCA) have been traditionally used in the study of Crohn's disease (CD). We applied ASCA in relation to obesity. This study aims (i) to determine the concentration of ASCA (immunoglobulin A [IgA] and immunoglobulin G [IgG]) in obese compared with normal weight individuals and (ii) to determine if there is a correlation between ASCA concentrations, obesity indices and C-reactive protein. Forty obese individuals (body mass index [BMI]>35kgm-2) and 18 healthy (BMI<25kgm-2) volunteers participated in this case-control study. Binding activity of serum IgA and IgG to the cell wall mannan of S.cerevisiae was measured by enzyme-linked immunosorbent assay. More than one-third of the obese individual (35%) showed elevated titres of ASCA compared with the control group (5%). This antibody was positively associated with weight (P=0.01), BMI (P=0.02) and waist circumference (P=0.02), but not with C-reactive protein. It seems that ASCA are not only specific for CD but are also associated with obesity. S.cerevisiae or a related antigen may play a role in the matrix of this complex condition.
Baker's yeast (Saccharomyces cerevisiae) and its cell wall components have been used as one of the alternatives to antibiotic growth promoters in the feed industry. Antibodies to cell wall mannan of this yeast (ASCA) have been traditionally used in the study of Crohn's disease (CD). We applied ASCA in relation to obesity. This study aims (i) to determine the concentration of ASCA (immunoglobulin A [IgA] and immunoglobulin G [IgG]) in obese compared with normal weight individuals and (ii) to determine if there is a correlation between ASCA concentrations, obesity indices and C-reactive protein. Forty obese individuals (body mass index [BMI] > 35 kg m(-2) ) and 18 healthy (BMI < 25 kg m(-2) ) volunteers participated in this case-control study. Binding activity of serum IgA and IgG to the cell wall mannan of S. cerevisiae was measured by enzyme-linked immunosorbent assay. More than one-third of the obese individual (35%) showed elevated titres of ASCA compared with the control group (5%). This antibody was positively associated with weight (P = 0.01), BMI (P = 0.02) and waist circumference (P = 0.02), but not with C-reactive protein. It seems that ASCA are not only specific for CD but are also associated with obesity. S. cerevisiae or a related antigen may play a role in the matrix of this complex condition.
Summary Baker's yeast (Saccharomyces cerevisiae) and its cell wall components have been used as one of the alternatives to antibiotic growth promoters in the feed industry. Antibodies to cell wall mannan of this yeast (ASCA) have been traditionally used in the study of Crohn's disease (CD). We applied ASCA in relation to obesity. This study aims (i) to determine the concentration of ASCA (immunoglobulin A [IgA] and immunoglobulin G [IgG]) in obese compared with normal weight individuals and (ii) to determine if there is a correlation between ASCA concentrations, obesity indices and C‐reactive protein. Forty obese individuals (body mass index [BMI] > 35 kg m−2) and 18 healthy (BMI < 25 kg m−2) volunteers participated in this case–control study. Binding activity of serum IgA and IgG to the cell wall mannan of S. cerevisiae was measured by enzyme‐linked immunosorbent assay. More than one‐third of the obese individual (35%) showed elevated titres of ASCA compared with the control group (5%). This antibody was positively associated with weight (P = 0.01), BMI (P = 0.02) and waist circumference (P = 0.02), but not with C‐reactive protein. It seems that ASCA are not only specific for CD but are also associated with obesity. S. cerevisiae or a related antigen may play a role in the matrix of this complex condition.
Author Martins, C.
Kulseng, B.
Salamati, S.
Author_xml – sequence: 1
  givenname: S.
  surname: Salamati
  fullname: Salamati, S.
  email: saideh.salamati@stolav.no
  organization: Center for Obesity, Department of Surgery, St. Olav Hospital - Trondheim University Hospital, Trondheim, Norway
– sequence: 2
  givenname: C.
  surname: Martins
  fullname: Martins, C.
  organization: Center for Obesity, Department of Surgery, St. Olav Hospital - Trondheim University Hospital, Trondheim, Norway
– sequence: 3
  givenname: B.
  surname: Kulseng
  fullname: Kulseng, B.
  organization: Center for Obesity, Department of Surgery, St. Olav Hospital - Trondheim University Hospital, Trondheim, Norway
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25611585$$D View this record in MEDLINE/PubMed
BookMark eNp9kU1v1DAQhi1URD_ogT-ALHGgPaS1N_5IjnRVCtKqXYkiJC7WxJm03iZ2sRPK_nsM2-6hEsxI9mj8vCNr3n2y44NHQt5wdsJznNrQnPAZ0_ULsse1rIoqd3e2NSt3yWFKK5ZDzVQtxSuyO5OKc1nJPXJ9BncY3ye6RkgjPfoC1t5CDMPaYqIWI_50yQEeU_Cju0FPnaehwYS50VIf4gA9fUB3czvSNDUrtGN6TV520Cc8fLwPyNeP59fzT8Xi6uLz_MOisFKJuqg7xrSw-Wy1bGRbaegEIDTScga65sqq1gqugTeyUl1O2wnWAMj8xNvygBxt5t7H8GPCNJrBJYt9Dx7DlAxXiolZXkGZ0XfP0FWYos-_y5TQJROK15l6-0hNzYCtuY9ugLg2T_vKwPEGsDGkFLHbIpyZP3aYbIf5a0dmT5-x1o0wuuDHCK7_n-LB9bj-92gzvzp7UhQbhUsj_toqIN4ZpUstzbfLC7NUi_nyO1uay_I3LKuoxQ
CitedBy_id crossref_primary_10_1016_j_autrev_2023_103486
crossref_primary_10_1016_j_soard_2020_10_021
crossref_primary_10_20935_AcadMed7468
crossref_primary_10_1080_17446651_2020_1719068
crossref_primary_10_1186_s40168_017_0319_x
crossref_primary_10_1016_j_ijfoodmicro_2016_08_011
crossref_primary_10_3390_foods11182768
crossref_primary_10_1016_j_bj_2023_100625
crossref_primary_10_3390_foods7040061
crossref_primary_10_1186_s40608_017_0164_2
crossref_primary_10_1016_j_clicom_2024_02_001
crossref_primary_10_1080_21505594_2018_1496779
crossref_primary_10_3390_foods8020070
crossref_primary_10_3390_foods9010089
crossref_primary_10_1016_j_lwt_2020_109918
Cites_doi 10.1023/A:1019926121972
10.1177/0961203309105131
10.1007/s10620-008-0322-y
10.1136/bmj.297.6656.1105
10.1136/gut.31.5.536
10.1371/journal.pone.0034233
10.1016/j.livsci.2007.01.134
10.1038/cmi.2009.47
10.1016/0195-6663(89)90025-1
10.1371/journal.pone.0012957
10.1155/2012/879151
10.1136/ard.62.5.455
10.1016/S0021-9258(18)72984-0
10.1016/j.nutres.2009.03.002
10.1046/j.1365-2249.2003.02166.x
10.1093/ps/84.4.634
10.3168/jds.S0022-0302(98)75697-8
10.1097/00054725-200403000-00006
10.1016/j.femsim.2004.03.006
10.1172/JCI58109
10.1046/j.1365-2672.2000.01128.x
10.1038/ismej.2007.23
10.3168/jds.S0022-0302(02)74277-X
10.1093/ps/85.3.476
10.54846/jshap/408
10.2323/jgam.51.83
10.1152/ajpgi.00024.2006
10.3168/jds.S0022-0302(93)77608-0
10.15232/S1080-7446(15)31633-8
10.2527/1991.6973016x
10.1007/s10620-010-1541-6
10.1371/journal.pone.0066019
10.3390/ijms10083531
10.1159/000201121
10.1097/00042737-200312000-00005
ContentType Journal Article
Copyright 2014 World Obesity
2014 World Obesity.
Clinical Obesity © 2015 World Obesity
Copyright_xml – notice: 2014 World Obesity
– notice: 2014 World Obesity.
– notice: Clinical Obesity © 2015 World Obesity
DBID BSCLL
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TS
K9.
M7N
DOI 10.1111/cob.12079
DatabaseName Istex
CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Physical Education Index
ProQuest Health & Medical Complete (Alumni)
Algology Mycology and Protozoology Abstracts (Microbiology C)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
ProQuest Health & Medical Complete (Alumni)
Physical Education Index
Algology Mycology and Protozoology Abstracts (Microbiology C)
DatabaseTitleList Algology Mycology and Protozoology Abstracts (Microbiology C)
ProQuest Health & Medical Complete (Alumni)
MEDLINE

Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1758-8111
EndPage 47
ExternalDocumentID 3564570571
25611585
10_1111_cob_12079
COB12079
ark_67375_WNG_P6LCPZ0P_N
Genre article
Research Support, Non-U.S. Gov't
Journal Article
Comparative Study
GrantInformation_xml – fundername: Regional Centre for Obesity, St. Olav University Hospital (RSSO), Trondheim, Norway
GroupedDBID 05W
0R~
1OC
31~
33P
4.4
50Y
53G
8-0
8-1
AAESR
AAHQN
AAIPD
AAMMB
AAMNL
AANHP
AANLZ
AASGY
AAXRX
AAYCA
AAZKR
ABCUV
ABDBF
ABJNI
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCZN
ACGFS
ACGOF
ACMXC
ACPOU
ACRPL
ACUHS
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
AEFGJ
AEIGN
AEUYR
AEYWJ
AFBPY
AFFPM
AFGKR
AFRAH
AFWVQ
AFZJQ
AGHNM
AGQPQ
AGXDD
AGYGG
AHBTC
AHMBA
AIACR
AIDQK
AIDYY
AITYG
AIURR
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
AVWKF
AZFZN
AZVAB
BDRZF
BFHJK
BHBCM
BMXJE
BRXPI
BSCLL
D-A
DCZOG
DRFUL
DRMAN
DRSTM
EBS
EJD
FEDTE
FUBAC
G-S
GODZA
HGLYW
HVGLF
HZ~
KBYEO
LATKE
LEEKS
LH4
LITHE
LOXES
LUTES
LYRES
MEWTI
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
MY.
MY~
O66
O9-
OIG
P2W
PQQKQ
ROL
RX1
SUPJJ
WBKPD
WHWMO
WIH
WIJ
WIK
WOHZO
WVDHM
WXSBR
ZZTAW
A00
AAHHS
ACCFJ
ADZOD
AEEZP
AEQDE
AFPWT
AIWBW
AJBDE
P4E
WYJ
AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7TS
K9.
M7N
ID FETCH-LOGICAL-c5649-9f0074cf00d75b5d87af4aeab5c10a7916c6dc417a1b586f6f6cf40baa516c1d3
ISSN 1758-8103
IngestDate Fri Sep 05 09:22:05 EDT 2025
Tue Oct 07 06:07:20 EDT 2025
Thu Jan 02 22:16:27 EST 2025
Wed Oct 01 06:04:34 EDT 2025
Thu Apr 24 23:04:18 EDT 2025
Wed Jan 22 16:28:48 EST 2025
Tue Sep 09 05:29:38 EDT 2025
IsPeerReviewed true
IsScholarly true
Issue 1
Keywords fungi
Saccharomyces cerevisiae
antibodies to cell wall mannan of baker's yeast (ASCA)
obesity
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
2014 World Obesity.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c5649-9f0074cf00d75b5d87af4aeab5c10a7916c6dc417a1b586f6f6cf40baa516c1d3
Notes ark:/67375/WNG-P6LCPZ0P-N
Regional Centre for Obesity, St. Olav University Hospital (RSSO), Trondheim, Norway
ArticleID:COB12079
istex:C6AAB7AAF234289915BDFB0B049A770114F2EBAF
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
PMID 25611585
PQID 1647304619
PQPubID 946374
PageCount 6
ParticipantIDs proquest_miscellaneous_1660421033
proquest_journals_1647304619
pubmed_primary_25611585
crossref_primary_10_1111_cob_12079
crossref_citationtrail_10_1111_cob_12079
wiley_primary_10_1111_cob_12079_COB12079
istex_primary_ark_67375_WNG_P6LCPZ0P_N
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2015-02
February 2015
2015-02-00
2015-Feb
20150201
PublicationDateYYYYMMDD 2015-02-01
PublicationDate_xml – month: 02
  year: 2015
  text: 2015-02
PublicationDecade 2010
PublicationPlace England
PublicationPlace_xml – name: England
– name: London
PublicationTitle Clinical obesity
PublicationTitleAlternate Clinical Obesity
PublicationYear 2015
Publisher Blackwell Publishing Ltd
Wiley Subscription Services, Inc
Publisher_xml – name: Blackwell Publishing Ltd
– name: Wiley Subscription Services, Inc
References Miles RD, Butcher GD, Henry PR, Littell RC. Effect of antibiotic growth promoters on broiler performance, intestinal growth parameters, and quantitative morphology. Poult Sci 2006; 85: 476-485.
Newbold C, Olvera-Ramirez A. The use of yeast-based probiotics to meet new challenges in ruminant production. J Anim Sci 2006; 84: 425.
Piva G, Belladonna S, Fusconi G, Sicbaldi F. Effects of yeast on dairy-cow performance, ruminal fermentation, blood components, and milk manufacturing properties. J Dairy Sci 1993; 76: 2717-2722.
Dai H, Li Z, Zhang Y, Lv P, Gao XM. Elevated levels of serum IgA against Saccharomyces cerevisiae mannan in patients with rheumatoid arthritis. Cell Mol Immunol 2009; 6: 361-366.
Turner JL, Dritz SS, Minton JE. Review: alternatives to conventional antimicrobials in swine diets. Prof Anim Sci 2001; 17: 217-226.
Dai H, Li Z, Zhang Y, Lv P, Gao XM. Elevated levels of serum antibodies against Saccharomyces cerevisiae mannan in patients with systemic lupus erythematosus. Lupus 2009; 18: 1087-1090.
Buts JP. Twenty-five years of research on Saccharomyces boulardii trophic effects: updates and perspectives. Dig Dis Sci 2009; 54: 15-18.
Hoffmann C, Dollive S, Grunberg S et al. Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents. PLoS ONE 2013; 8: e66019.
Pang X, Hua X, Yang Q et al. Inter-species transplantation of gut microbiota from human to pigs. ISME J 2007; 1: 156-162.
Mendall MA, Gunasekera AV, John BJ, Kumar D. Is obesity a risk factor for Crohn's disease? Dig Dis Sci 2011; 56: 837-844.
Muratori P, Muratori L, Guidi M et al. Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases. Clin Exp Immunol 2003; 132: 473-476.
Konrad A, Rutten C, Flogerzi B et al. Immune sensitization to yeast antigens in ASCA-positive patients with Crohn's disease. Inflamm Bowel Dis 2004; 10: 97-105.
Harrer M, Reinisch W, Dejaco C et al. Do high serum levels of anti-Saccharomyces cerevisiae antibodies result from a leakiness of the gut barrier in Crohn's disease? Eur J Gastroenterol Hepatol 2003; 15: 1281-1285.
von Dongern E. Beitrage zur immunitatslehre. Münchener Med Wochenschr 1900; 47: 677-680.
Kabir SML. The role of probiotics in the poultry industry. Int J Mol Sci 2009; 10: 3531-3546.
Miller-Webster T, Hoover WH, Holt M, Nocek JE. Influence of yeast culture on ruminal microbial metabolism in continuous culture. J Dairy Sci 2002; 85: 2009-2014.
Damoiseaux JG, Bouten B, Linders AM et al. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: high prevalence in patients with celiac disease. J Clin Immunol 2002; 22: 281-288.
Main J, McKenzie H, Yeaman GR et al. Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease. BMJ 1988; 297: 1105-1106.
Larsson B, Seidell J, Svardsudd K et al. Obesity, adipose tissue distribution and health in men - the study of men born in 1913. Appetite 1913; 13: 37-44.
Pillemer L, Ecker E. Anticomplementary factor in fresh yeast. J Biol Chem 1941; 137: 139-142.
Kohl A, Gogebakan O, Mohlig M et al. Increased interleukin-10 but unchanged insulin sensitivity after 4 weeks of (1, 3)(1, 6)-β-glycan consumption in overweight humans. Nutr Res 2009; 29: 248-254.
Kogan G, Kocher A. Role of yeast cell wall polysaccharides in pig nutrition and health protection. Livest Sci 2007; 109: 161-165.
Schulze J, Sonnenborn U. Yeasts in the gut: from commensals to infectious agents. Deutsch Arztebl Int 2009; 106: 837-842.
Young CA, Sonnenberg A, Burns EA. Lymphocyte proliferation response to baker's yeast in Crohn's disease. Digestion 1994; 55: 40-43.
Krause I, Monselise Y, Milo G, Weinberger A. Anti-Saccharomyces cerevisiae antibodies - a novel serologic marker for Behçet's disease. Clin Exp Rheumatol 2002; 20(Suppl. 26): 21-24.
Williams PEV, Tait CAG, Innes GM, Newbold CJ. Effects of the inclusion of yeast culture (Saccharomyces cerevisiae plus growth-medium) in the diet of dairy-cows on milk-yield and forage degradation and fermentation patterns in the rumen of steers. J Anim Sci 1991; 69: 3016-3026.
Lam YY, Ha CW, Campbell CR et al. Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PLoS ONE 2012; 7: e34233.
Brun P, Castagliuolo I, Di Leo V et al. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2007; 292: G518-G525.
Saegusa S, Totsuka M, Kaminogawa S, Hosoi T. Candida albicans and Saccharomyces cerevisiae induce interleukin-8 production from intestinal epithelial-like Caco-2 cells in the presence of butyric acid. FEMS Immunol Med Microbiol 2004; 41: 227-235.
Hoffman IE, Demetter P, Peeters M et al. Anti-Saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy. Ann Rheum Dis 2003; 62: 455-459.
McKenzie H, Main J, Pennington CR, Parratt D. Antibody to selected strains of Saccharomyces cerevisiae (bakers and brewers-yeast) and Candida albicans in Crohn's disease. Gut 1990; 31: 536-538.
Miguel JC, Rodriguez-Zas SL, Pettigrew JE. Efficacy of a mannan oligosaccharide (Bio-Mos((R))) for improving nursery pig performance. J Swine Health Prod 2004; 12: 296-307.
Dibner JJ, Richards JD. Antibiotic growth promoters in agriculture: history and mode of action. Poult Sci 2005; 84: 634-643.
Wohlt JE, Corcione TT, Zajac PK. Effect of yeast on feed intake and performance of cows fed diets based on corn silage during early lactation. J Dairy Sci 1998; 81: 1345-1352.
Martins FS, Nardi RMD, Arantes RME et al. Screening of yeasts as probiotic based on capacities to colonize the gastrointestinal tract and to protect against enteropathogen challenge in mice. J Gen Appl Microbiol 2005; 51: 83-92.
Harris K, Kassis A, Major G, Chou CJ. Is the gut microbiota a new factor contributing to obesity and its metabolic disorders? J Obes 2012; 2012: 1-14.
Papp M, Norman GL, Vitalis Z et al. Presence of anti-microbial antibodies in liver cirrhosis - a tell-tale sign of compromised immunity? PLoS ONE 2010; 5: e12957.
Tilg H, Kaser A. Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest 2011; 121: 2126-2132.
Rodrigues ACP, Cara DC, Fretez SHGG et al. Saccharomyces boulardii stimulates slgA production and the phagocytic system of gnotobiotic mice. J Appl Microbiol 2000; 89: 404-414.
1990; 31
2004; 41
2012; 2012
1941; 137
2000; 89
2005; 84
2003; 15
1998; 81
2011; 56
1913; 13
2013; 8
2007; 109
2003; 132
2009; 29
2004; 10
2006; 85
1991; 69
2009; 10
2009; 54
2006; 84
2002; 85
2002; 20
2007; 292
1993; 76
2004; 12
2002; 22
2005; 51
1994; 55
1988; 297
2009; 6
1900; 47
2001; 17
2007; 1
2012; 7
2010; 5
2003; 62
2011; 121
2009; 18
2009; 106
e_1_2_10_23_1
e_1_2_10_24_1
e_1_2_10_21_1
e_1_2_10_22_1
e_1_2_10_20_1
Miguel JC (e_1_2_10_6_1) 2004; 12
Pillemer L (e_1_2_10_33_1) 1941; 137
Krause I (e_1_2_10_16_1) 2002; 20
e_1_2_10_2_1
e_1_2_10_4_1
e_1_2_10_18_1
e_1_2_10_3_1
e_1_2_10_19_1
e_1_2_10_39_1
e_1_2_10_5_1
e_1_2_10_17_1
e_1_2_10_38_1
e_1_2_10_8_1
e_1_2_10_14_1
e_1_2_10_37_1
e_1_2_10_7_1
e_1_2_10_15_1
e_1_2_10_36_1
e_1_2_10_12_1
e_1_2_10_35_1
e_1_2_10_13_1
e_1_2_10_34_1
e_1_2_10_10_1
e_1_2_10_11_1
e_1_2_10_31_1
e_1_2_10_30_1
Newbold C (e_1_2_10_9_1) 2006; 84
Dongern E (e_1_2_10_32_1) 1900; 47
Schulze J (e_1_2_10_40_1) 2009; 106
e_1_2_10_29_1
e_1_2_10_27_1
e_1_2_10_28_1
e_1_2_10_25_1
e_1_2_10_26_1
References_xml – reference: Mendall MA, Gunasekera AV, John BJ, Kumar D. Is obesity a risk factor for Crohn's disease? Dig Dis Sci 2011; 56: 837-844.
– reference: Brun P, Castagliuolo I, Di Leo V et al. Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis. Am J Physiol Gastrointest Liver Physiol 2007; 292: G518-G525.
– reference: Schulze J, Sonnenborn U. Yeasts in the gut: from commensals to infectious agents. Deutsch Arztebl Int 2009; 106: 837-842.
– reference: Miles RD, Butcher GD, Henry PR, Littell RC. Effect of antibiotic growth promoters on broiler performance, intestinal growth parameters, and quantitative morphology. Poult Sci 2006; 85: 476-485.
– reference: Williams PEV, Tait CAG, Innes GM, Newbold CJ. Effects of the inclusion of yeast culture (Saccharomyces cerevisiae plus growth-medium) in the diet of dairy-cows on milk-yield and forage degradation and fermentation patterns in the rumen of steers. J Anim Sci 1991; 69: 3016-3026.
– reference: Rodrigues ACP, Cara DC, Fretez SHGG et al. Saccharomyces boulardii stimulates slgA production and the phagocytic system of gnotobiotic mice. J Appl Microbiol 2000; 89: 404-414.
– reference: Pillemer L, Ecker E. Anticomplementary factor in fresh yeast. J Biol Chem 1941; 137: 139-142.
– reference: Pang X, Hua X, Yang Q et al. Inter-species transplantation of gut microbiota from human to pigs. ISME J 2007; 1: 156-162.
– reference: Kogan G, Kocher A. Role of yeast cell wall polysaccharides in pig nutrition and health protection. Livest Sci 2007; 109: 161-165.
– reference: Konrad A, Rutten C, Flogerzi B et al. Immune sensitization to yeast antigens in ASCA-positive patients with Crohn's disease. Inflamm Bowel Dis 2004; 10: 97-105.
– reference: Buts JP. Twenty-five years of research on Saccharomyces boulardii trophic effects: updates and perspectives. Dig Dis Sci 2009; 54: 15-18.
– reference: Harris K, Kassis A, Major G, Chou CJ. Is the gut microbiota a new factor contributing to obesity and its metabolic disorders? J Obes 2012; 2012: 1-14.
– reference: Tilg H, Kaser A. Gut microbiome, obesity, and metabolic dysfunction. J Clin Invest 2011; 121: 2126-2132.
– reference: Dibner JJ, Richards JD. Antibiotic growth promoters in agriculture: history and mode of action. Poult Sci 2005; 84: 634-643.
– reference: von Dongern E. Beitrage zur immunitatslehre. Münchener Med Wochenschr 1900; 47: 677-680.
– reference: Kabir SML. The role of probiotics in the poultry industry. Int J Mol Sci 2009; 10: 3531-3546.
– reference: Muratori P, Muratori L, Guidi M et al. Anti-Saccharomyces cerevisiae antibodies (ASCA) and autoimmune liver diseases. Clin Exp Immunol 2003; 132: 473-476.
– reference: Dai H, Li Z, Zhang Y, Lv P, Gao XM. Elevated levels of serum antibodies against Saccharomyces cerevisiae mannan in patients with systemic lupus erythematosus. Lupus 2009; 18: 1087-1090.
– reference: Martins FS, Nardi RMD, Arantes RME et al. Screening of yeasts as probiotic based on capacities to colonize the gastrointestinal tract and to protect against enteropathogen challenge in mice. J Gen Appl Microbiol 2005; 51: 83-92.
– reference: Damoiseaux JG, Bouten B, Linders AM et al. Diagnostic value of anti-Saccharomyces cerevisiae and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: high prevalence in patients with celiac disease. J Clin Immunol 2002; 22: 281-288.
– reference: Miguel JC, Rodriguez-Zas SL, Pettigrew JE. Efficacy of a mannan oligosaccharide (Bio-Mos((R))) for improving nursery pig performance. J Swine Health Prod 2004; 12: 296-307.
– reference: Turner JL, Dritz SS, Minton JE. Review: alternatives to conventional antimicrobials in swine diets. Prof Anim Sci 2001; 17: 217-226.
– reference: Hoffmann C, Dollive S, Grunberg S et al. Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents. PLoS ONE 2013; 8: e66019.
– reference: Dai H, Li Z, Zhang Y, Lv P, Gao XM. Elevated levels of serum IgA against Saccharomyces cerevisiae mannan in patients with rheumatoid arthritis. Cell Mol Immunol 2009; 6: 361-366.
– reference: Saegusa S, Totsuka M, Kaminogawa S, Hosoi T. Candida albicans and Saccharomyces cerevisiae induce interleukin-8 production from intestinal epithelial-like Caco-2 cells in the presence of butyric acid. FEMS Immunol Med Microbiol 2004; 41: 227-235.
– reference: Miller-Webster T, Hoover WH, Holt M, Nocek JE. Influence of yeast culture on ruminal microbial metabolism in continuous culture. J Dairy Sci 2002; 85: 2009-2014.
– reference: Kohl A, Gogebakan O, Mohlig M et al. Increased interleukin-10 but unchanged insulin sensitivity after 4 weeks of (1, 3)(1, 6)-β-glycan consumption in overweight humans. Nutr Res 2009; 29: 248-254.
– reference: Larsson B, Seidell J, Svardsudd K et al. Obesity, adipose tissue distribution and health in men - the study of men born in 1913. Appetite 1913; 13: 37-44.
– reference: Papp M, Norman GL, Vitalis Z et al. Presence of anti-microbial antibodies in liver cirrhosis - a tell-tale sign of compromised immunity? PLoS ONE 2010; 5: e12957.
– reference: Main J, McKenzie H, Yeaman GR et al. Antibody to Saccharomyces cerevisiae (bakers' yeast) in Crohn's disease. BMJ 1988; 297: 1105-1106.
– reference: Harrer M, Reinisch W, Dejaco C et al. Do high serum levels of anti-Saccharomyces cerevisiae antibodies result from a leakiness of the gut barrier in Crohn's disease? Eur J Gastroenterol Hepatol 2003; 15: 1281-1285.
– reference: McKenzie H, Main J, Pennington CR, Parratt D. Antibody to selected strains of Saccharomyces cerevisiae (bakers and brewers-yeast) and Candida albicans in Crohn's disease. Gut 1990; 31: 536-538.
– reference: Lam YY, Ha CW, Campbell CR et al. Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet-induced obese mice. PLoS ONE 2012; 7: e34233.
– reference: Wohlt JE, Corcione TT, Zajac PK. Effect of yeast on feed intake and performance of cows fed diets based on corn silage during early lactation. J Dairy Sci 1998; 81: 1345-1352.
– reference: Piva G, Belladonna S, Fusconi G, Sicbaldi F. Effects of yeast on dairy-cow performance, ruminal fermentation, blood components, and milk manufacturing properties. J Dairy Sci 1993; 76: 2717-2722.
– reference: Hoffman IE, Demetter P, Peeters M et al. Anti-Saccharomyces cerevisiae IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy. Ann Rheum Dis 2003; 62: 455-459.
– reference: Krause I, Monselise Y, Milo G, Weinberger A. Anti-Saccharomyces cerevisiae antibodies - a novel serologic marker for Behçet's disease. Clin Exp Rheumatol 2002; 20(Suppl. 26): 21-24.
– reference: Newbold C, Olvera-Ramirez A. The use of yeast-based probiotics to meet new challenges in ruminant production. J Anim Sci 2006; 84: 425.
– reference: Young CA, Sonnenberg A, Burns EA. Lymphocyte proliferation response to baker's yeast in Crohn's disease. Digestion 1994; 55: 40-43.
– volume: 1
  start-page: 156
  year: 2007
  end-page: 162
  article-title: Inter‐species transplantation of gut microbiota from human to pigs
  publication-title: ISME J
– volume: 13
  start-page: 37
  year: 1913
  end-page: 44
  article-title: Obesity, adipose tissue distribution and health in men – the study of men born in 1913
  publication-title: Appetite
– volume: 2012
  start-page: 1
  year: 2012
  end-page: 14
  article-title: Is the gut microbiota a new factor contributing to obesity and its metabolic disorders?
  publication-title: J Obes
– volume: 109
  start-page: 161
  year: 2007
  end-page: 165
  article-title: Role of yeast cell wall polysaccharides in pig nutrition and health protection
  publication-title: Livest Sci
– volume: 31
  start-page: 536
  year: 1990
  end-page: 538
  article-title: Antibody to selected strains of (bakers and brewers‐yeast) and in Crohn's disease
  publication-title: Gut
– volume: 89
  start-page: 404
  year: 2000
  end-page: 414
  article-title: stimulates slgA production and the phagocytic system of gnotobiotic mice
  publication-title: J Appl Microbiol
– volume: 69
  start-page: 3016
  year: 1991
  end-page: 3026
  article-title: Effects of the inclusion of yeast culture ( plus growth‐medium) in the diet of dairy‐cows on milk‐yield and forage degradation and fermentation patterns in the rumen of steers
  publication-title: J Anim Sci
– volume: 55
  start-page: 40
  year: 1994
  end-page: 43
  article-title: Lymphocyte proliferation response to baker's yeast in Crohn's disease
  publication-title: Digestion
– volume: 47
  start-page: 677
  year: 1900
  end-page: 680
  article-title: Beitrage zur immunitatslehre
  publication-title: Münchener Med Wochenschr
– volume: 7
  start-page: e34233
  year: 2012
  article-title: Increased gut permeability and microbiota change associate with mesenteric fat inflammation and metabolic dysfunction in diet‐induced obese mice
  publication-title: PLoS ONE
– volume: 84
  start-page: 634
  year: 2005
  end-page: 643
  article-title: Antibiotic growth promoters in agriculture: history and mode of action
  publication-title: Poult Sci
– volume: 84
  start-page: 425
  year: 2006
  article-title: The use of yeast‐based probiotics to meet new challenges in ruminant production
  publication-title: J Anim Sci
– volume: 29
  start-page: 248
  year: 2009
  end-page: 254
  article-title: Increased interleukin‐10 but unchanged insulin sensitivity after 4 weeks of (1, 3)(1, 6)‐β‐glycan consumption in overweight humans
  publication-title: Nutr Res
– volume: 62
  start-page: 455
  year: 2003
  end-page: 459
  article-title: Anti‐ IgA antibodies are raised in ankylosing spondylitis and undifferentiated spondyloarthropathy
  publication-title: Ann Rheum Dis
– volume: 121
  start-page: 2126
  year: 2011
  end-page: 2132
  article-title: Gut microbiome, obesity, and metabolic dysfunction
  publication-title: J Clin Invest
– volume: 54
  start-page: 15
  year: 2009
  end-page: 18
  article-title: Twenty‐five years of research on trophic effects: updates and perspectives
  publication-title: Dig Dis Sci
– volume: 8
  start-page: e66019
  year: 2013
  article-title: Archaea and fungi of the human gut microbiome: correlations with diet and bacterial residents
  publication-title: PLoS ONE
– volume: 297
  start-page: 1105
  year: 1988
  end-page: 1106
  article-title: Antibody to (bakers’ yeast) in Crohn's disease
  publication-title: BMJ
– volume: 41
  start-page: 227
  year: 2004
  end-page: 235
  article-title: and induce interleukin‐8 production from intestinal epithelial‐like Caco‐2 cells in the presence of butyric acid
  publication-title: FEMS Immunol Med Microbiol
– volume: 106
  start-page: 837
  year: 2009
  end-page: 842
  article-title: Yeasts in the gut: from commensals to infectious agents
  publication-title: Deutsch Arztebl Int
– volume: 51
  start-page: 83
  year: 2005
  end-page: 92
  article-title: Screening of yeasts as probiotic based on capacities to colonize the gastrointestinal tract and to protect against enteropathogen challenge in mice
  publication-title: J Gen Appl Microbiol
– volume: 137
  start-page: 139
  year: 1941
  end-page: 142
  article-title: Anticomplementary factor in fresh yeast
  publication-title: J Biol Chem
– volume: 6
  start-page: 361
  year: 2009
  end-page: 366
  article-title: Elevated levels of serum IgA against mannan in patients with rheumatoid arthritis
  publication-title: Cell Mol Immunol
– volume: 5
  start-page: e12957
  year: 2010
  article-title: Presence of anti‐microbial antibodies in liver cirrhosis – a tell‐tale sign of compromised immunity?
  publication-title: PLoS ONE
– volume: 132
  start-page: 473
  year: 2003
  end-page: 476
  article-title: Anti‐ antibodies (ASCA) and autoimmune liver diseases
  publication-title: Clin Exp Immunol
– volume: 76
  start-page: 2717
  year: 1993
  end-page: 2722
  article-title: Effects of yeast on dairy‐cow performance, ruminal fermentation, blood components, and milk manufacturing properties
  publication-title: J Dairy Sci
– volume: 56
  start-page: 837
  year: 2011
  end-page: 844
  article-title: Is obesity a risk factor for Crohn's disease?
  publication-title: Dig Dis Sci
– volume: 292
  start-page: G518
  year: 2007
  end-page: G525
  article-title: Increased intestinal permeability in obese mice: new evidence in the pathogenesis of nonalcoholic steatohepatitis
  publication-title: Am J Physiol Gastrointest Liver Physiol
– volume: 22
  start-page: 281
  year: 2002
  end-page: 288
  article-title: Diagnostic value of anti‐ and antineutrophil cytoplasmic antibodies for inflammatory bowel disease: high prevalence in patients with celiac disease
  publication-title: J Clin Immunol
– volume: 18
  start-page: 1087
  year: 2009
  end-page: 1090
  article-title: Elevated levels of serum antibodies against mannan in patients with systemic lupus erythematosus
  publication-title: Lupus
– volume: 81
  start-page: 1345
  year: 1998
  end-page: 1352
  article-title: Effect of yeast on feed intake and performance of cows fed diets based on corn silage during early lactation
  publication-title: J Dairy Sci
– volume: 10
  start-page: 3531
  year: 2009
  end-page: 3546
  article-title: The role of probiotics in the poultry industry
  publication-title: Int J Mol Sci
– volume: 15
  start-page: 1281
  year: 2003
  end-page: 1285
  article-title: Do high serum levels of anti‐ antibodies result from a leakiness of the gut barrier in Crohn's disease?
  publication-title: Eur J Gastroenterol Hepatol
– volume: 12
  start-page: 296
  year: 2004
  end-page: 307
  article-title: Efficacy of a mannan oligosaccharide (Bio‐Mos((R))) for improving nursery pig performance
  publication-title: J Swine Health Prod
– volume: 85
  start-page: 476
  year: 2006
  end-page: 485
  article-title: Effect of antibiotic growth promoters on broiler performance, intestinal growth parameters, and quantitative morphology
  publication-title: Poult Sci
– volume: 85
  start-page: 2009
  year: 2002
  end-page: 2014
  article-title: Influence of yeast culture on ruminal microbial metabolism in continuous culture
  publication-title: J Dairy Sci
– volume: 17
  start-page: 217
  year: 2001
  end-page: 226
  article-title: Review: alternatives to conventional antimicrobials in swine diets
  publication-title: Prof Anim Sci
– volume: 20
  start-page: 21
  issue: Suppl. 26
  year: 2002
  end-page: 24
  article-title: Anti‐ antibodies – a novel serologic marker for Behçet's disease
  publication-title: Clin Exp Rheumatol
– volume: 10
  start-page: 97
  year: 2004
  end-page: 105
  article-title: Immune sensitization to yeast antigens in ASCA‐positive patients with Crohn's disease
  publication-title: Inflamm Bowel Dis
– ident: e_1_2_10_25_1
  doi: 10.1023/A:1019926121972
– ident: e_1_2_10_23_1
  doi: 10.1177/0961203309105131
– ident: e_1_2_10_36_1
  doi: 10.1007/s10620-008-0322-y
– ident: e_1_2_10_15_1
  doi: 10.1136/bmj.297.6656.1105
– ident: e_1_2_10_20_1
  doi: 10.1136/gut.31.5.536
– ident: e_1_2_10_31_1
  doi: 10.1371/journal.pone.0034233
– ident: e_1_2_10_7_1
  doi: 10.1016/j.livsci.2007.01.134
– ident: e_1_2_10_22_1
  doi: 10.1038/cmi.2009.47
– ident: e_1_2_10_30_1
  doi: 10.1016/0195-6663(89)90025-1
– ident: e_1_2_10_19_1
  doi: 10.1371/journal.pone.0012957
– ident: e_1_2_10_2_1
  doi: 10.1155/2012/879151
– ident: e_1_2_10_24_1
  doi: 10.1136/ard.62.5.455
– volume: 137
  start-page: 139
  year: 1941
  ident: e_1_2_10_33_1
  article-title: Anticomplementary factor in fresh yeast
  publication-title: J Biol Chem
  doi: 10.1016/S0021-9258(18)72984-0
– ident: e_1_2_10_34_1
  doi: 10.1016/j.nutres.2009.03.002
– volume: 20
  start-page: 21
  issue: 26
  year: 2002
  ident: e_1_2_10_16_1
  article-title: Anti‐Saccharomyces cerevisiae antibodies – a novel serologic marker for Behçet's disease
  publication-title: Clin Exp Rheumatol
– ident: e_1_2_10_18_1
  doi: 10.1046/j.1365-2249.2003.02166.x
– ident: e_1_2_10_3_1
  doi: 10.1093/ps/84.4.634
– ident: e_1_2_10_11_1
  doi: 10.3168/jds.S0022-0302(98)75697-8
– ident: e_1_2_10_17_1
  doi: 10.1097/00054725-200403000-00006
– volume: 47
  start-page: 677
  year: 1900
  ident: e_1_2_10_32_1
  article-title: Beitrage zur immunitatslehre
  publication-title: Münchener Med Wochenschr
– ident: e_1_2_10_37_1
  doi: 10.1016/j.femsim.2004.03.006
– ident: e_1_2_10_21_1
  doi: 10.1172/JCI58109
– ident: e_1_2_10_35_1
  doi: 10.1046/j.1365-2672.2000.01128.x
– ident: e_1_2_10_8_1
  doi: 10.1038/ismej.2007.23
– ident: e_1_2_10_14_1
  doi: 10.3168/jds.S0022-0302(02)74277-X
– ident: e_1_2_10_4_1
  doi: 10.1093/ps/85.3.476
– volume: 12
  start-page: 296
  year: 2004
  ident: e_1_2_10_6_1
  article-title: Efficacy of a mannan oligosaccharide (Bio‐Mos((R))) for improving nursery pig performance
  publication-title: J Swine Health Prod
  doi: 10.54846/jshap/408
– ident: e_1_2_10_39_1
  doi: 10.2323/jgam.51.83
– volume: 106
  start-page: 837
  year: 2009
  ident: e_1_2_10_40_1
  article-title: Yeasts in the gut: from commensals to infectious agents
  publication-title: Deutsch Arztebl Int
– ident: e_1_2_10_28_1
  doi: 10.1152/ajpgi.00024.2006
– ident: e_1_2_10_13_1
  doi: 10.3168/jds.S0022-0302(93)77608-0
– ident: e_1_2_10_5_1
  doi: 10.15232/S1080-7446(15)31633-8
– volume: 84
  start-page: 425
  year: 2006
  ident: e_1_2_10_9_1
  article-title: The use of yeast‐based probiotics to meet new challenges in ruminant production
  publication-title: J Anim Sci
– ident: e_1_2_10_10_1
  doi: 10.2527/1991.6973016x
– ident: e_1_2_10_29_1
  doi: 10.1007/s10620-010-1541-6
– ident: e_1_2_10_38_1
  doi: 10.1371/journal.pone.0066019
– ident: e_1_2_10_12_1
  doi: 10.3390/ijms10083531
– ident: e_1_2_10_26_1
  doi: 10.1159/000201121
– ident: e_1_2_10_27_1
  doi: 10.1097/00042737-200312000-00005
SSID ssj0000626954
Score 1.9913292
Snippet Summary Baker's yeast (Saccharomyces cerevisiae) and its cell wall components have been used as one of the alternatives to antibiotic growth promoters in the...
Baker's yeast (Saccharomyces cerevisiae) and its cell wall components have been used as one of the alternatives to antibiotic growth promoters in the feed...
Summary Baker's yeast (Saccharomyces cerevisiae) and its cell wall components have been used as one of the alternatives to antibiotic growth promoters in the...
SourceID proquest
pubmed
crossref
wiley
istex
SourceType Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 42
SubjectTerms Adult
antibodies to cell wall mannan of baker's yeast (ASCA)
Antibodies, Fungal - immunology
Body mass index
C-Reactive Protein - immunology
Case-Control Studies
Cell Wall - immunology
Crohn Disease - immunology
Crohn Disease - microbiology
Enzyme-Linked Immunosorbent Assay
Female
Food Hypersensitivity - immunology
fungi
Humans
Ideal Body Weight - immunology
Immunoglobulin A - immunology
Immunoglobulin G - immunology
Male
Obesity
Obesity - immunology
Phenotype
Probiotics
Saccharomyces cerevisiae
Saccharomyces cerevisiae - immunology
Yeast
Title Baker's yeast (Saccharomyces cerevisiae) antigen in obese and normal weight subjects
URI https://api.istex.fr/ark:/67375/WNG-P6LCPZ0P-N/fulltext.pdf
https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fcob.12079
https://www.ncbi.nlm.nih.gov/pubmed/25611585
https://www.proquest.com/docview/1647304619
https://www.proquest.com/docview/1660421033
Volume 5
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVEBS
  databaseName: EBSCOhost Academic Search Ultimate
  customDbUrl: https://search.ebscohost.com/login.aspx?authtype=ip,shib&custid=s3936755&profile=ehost&defaultdb=asn
  eissn: 1758-8111
  dateEnd: 20241105
  omitProxy: true
  ssIdentifier: ssj0000626954
  issn: 1758-8103
  databaseCode: ABDBF
  dateStart: 20130201
  isFulltext: true
  titleUrlDefault: https://search.ebscohost.com/direct.asp?db=asn
  providerName: EBSCOhost
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3rb9MwELdYKyG-IN4UxmQQgqEoVdzGeXxcCmMCWip106Z9iWzHkSZGgpZWMP56zo-4LeukgSpZkeMkte_n8935fIfQ65AVQ5nGpR-FLPBDEUY-k7H0E16ykohIML1jOp5EB0fhpxN6sjx7ok-XzHlf_N54ruR_qAp1QFd1SvYfKOteChVwDfSFEigM5Y1onDHtExE33qVKwaOkRW_mMaGOUtXfL5WzldB-vM0ZU7Jk6sE4qvCbyspRc9mYvYNKya3n3k9tJfWaBVe2mWZVbB215ydrk0fA2WUYAIoZj4BZf2ndVqEJTOwCV_l5AYuwYSxZf9XWQGjrnuzYI2gXfkICw5Lkap1lmZan0ivQMfzRRNKyK60JtXkNDxc175NBYDLNrMfJ_mv9cl6FrT4Dj-b60S3UHQCzDzqou5e9z_ad8S0ANS7VGfJcj2zUKeXl5T69Jqt01bT7tUkRWddrtGByeA_dtRoF3jPwuI9uyeoBuj22PhMP0bFGydsGa4zgXTzDqwjBS4Tgd9jiA59VWOMDKgps8IENPnCLj0foaP_D4ejAt-k0fEGjMPXTUsmLAsoippwWSczKkEnGqSABi0FPEFEhQhIzwmkSlfATZRhwxijcIsXwMepUdSWfIpxKmsLjBawHoBLwIiFlIpjkrFTh3Qakh3bbgcuFjTWvUp6c51do1EOvXNMfJsDKpkZv9Oi7Fuzim_JIjGl-PPmYT6Mvo-lpMM0nPbTdkie3E7XJVcg8nVgA3vPS3QY2qvbGWCXrhWoTwfIFOBj20BNDVvcx0ApAb0oo9ErT-fr_mY--Zvri2U169RzdWU6ybdSZXyzkCxBx53zHAnYHbU2m4z8oeKOp
linkProvider EBSCOhost
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Baker%27s+yeast+%28+S+accharomyces+cerevisiae+%29+antigen+in+obese+and+normal+weight+subjects&rft.jtitle=Clinical+obesity&rft.au=Salamati%2C+S.&rft.au=Martins%2C+C.&rft.au=Kulseng%2C+B.&rft.date=2015-02-01&rft.issn=1758-8103&rft.eissn=1758-8111&rft.volume=5&rft.issue=1&rft.spage=42&rft.epage=47&rft_id=info:doi/10.1111%2Fcob.12079&rft.externalDBID=n%2Fa&rft.externalDocID=10_1111_cob_12079
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1758-8103&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1758-8103&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1758-8103&client=summon